Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on immune and sexual health. Browse all Immune & Sexual Health education

Genital herpes is one of the most common sexually transmitted infections, caused by the herpes simplex virus (HSV-1 or HSV-2). Exposure is widespread, yet outcomes vary enormously: some people never notice symptoms, while others experience recurrent outbreaks. Part of that variation is behavioral and viral, but a growing body of research shows that host genetics — how your immune system recognizes and controls the virus — also plays a measurable role.

Understanding HSV and Why Susceptibility Differs

HSV spreads through skin-to-skin contact and, once acquired, establishes lifelong latency in nerve cells, reactivating periodically. There is no cure, and susceptibility to acquiring the virus and the frequency of reactivation differ between people. Those differences reflect a mix of exposure, viral type, immune status, and inherited immune biology. HSV-1, historically tied to oral cold sores, now accounts for a growing share of genital cases, while HSV-2 remains the more common cause of recurrent genital outbreaks. Understanding the genetic layer does not change that prevention centers on established, evidence-based precautions — but it does help explain the wide range of individual experiences.

The Immune Genes: HLA and TLR3

The HLA (human leukocyte antigen) system determines how immune cells display viral fragments to trigger a response, and specific HLA class I alleles have been associated with differences in HSV control. Innate immunity matters too: TLR3 (Toll-like receptor 3) senses viral genetic material, and rare TLR3-pathway variants are well documented in severe HSV disease such as herpes encephalitis. These genes describe how efficiently your immune system detects and contains the virus — a tendency, not a verdict.

C21orf91 and Outbreak-Frequency Research

Genome-wide research on cold sores (herpes labialis) identified a susceptibility signal near C21orf91 on chromosome 21, associated with how often people experience recurrent HSV-1 outbreaks. Studies of the interferon-lambda gene IFNL3 (also called IL28B) have likewise explored antiviral response differences. This work is still maturing, but it reinforces a central point: reactivation frequency is shaped partly by inherited antiviral signaling, which is why two people with the same virus can have very different experiences.

Evidence-Based Risk Reduction

Genetics does not replace prevention, and no genetic result lowers risk on its own. The established, evidence-based ways to reduce transmission and acquisition — consistent condom use, open communication with partners, avoiding contact during active outbreaks, and appropriate medical care — remain the foundation. Anyone with concerns about exposure, symptoms, or a partner's status should speak with a qualified healthcare provider, who can advise on testing and management tailored to the individual.

Where Genetic Insight Fits In

The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights across immune and antiviral-signaling pathways, among others. It does not test for HSV, diagnose infection, predict outbreaks, or prevent transmission. It offers pathway-level education about your immune biology — context you can bring to a broader conversation with your provider about overall health and prevention.

Frequently Asked Questions About Genital Herpes and Genetics

Is susceptibility to genital herpes genetic?

Partly. Whether someone acquires HSV depends heavily on exposure, but inherited immune genes such as HLA alleles and TLR3 influence how the body detects and controls the virus. Research near C21orf91 also links genetics to outbreak frequency. Genetics is one factor among exposure, viral type, and overall immune health.

Can a genetic test tell me if I have herpes?

No. Genital herpes is diagnosed through specific medical tests — such as viral PCR, culture, or type-specific antibody testing — ordered by a healthcare provider. A pathway-level genetic test does not detect the virus or diagnose infection. It offers educational context about immune biology, not a diagnosis or screening result.

How can I lower my risk of genital herpes?

Evidence-based prevention includes consistent condom use, honest communication with partners, avoiding contact during active outbreaks, and seeking timely medical care. Genetic insight does not reduce risk by itself. A qualified healthcare provider can discuss testing, prevention, and management options suited to your specific circumstances.

Curious how your own biology reads at the pathway level? The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — giving you educational context about the pathways discussed here, not a diagnosis. Genetics is a guide, not a guarantee, and your results are a starting point for a conversation with your provider.

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use, and it does not diagnose, treat, or prevent any condition. Consult a qualified healthcare provider before beginning any peptide protocol or making changes to your care.

This article is part of the PlexusDx Education Hub. Browse all Immune & Sexual Health education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.